Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MSI-H/dMMR + TMB-H + PD-L1 overexpression
i
Other names:
TMB | Tumor Mutational Burden, PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule, MSI | Microsatellite instability
Associations
(2)
News
Trials
C4 | Sensitive
C4 | Resistant
Show legend
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Small Intestinal Carcinoma
Pancreatic Ductal Adenocarcinoma
nivolumab + ipilimumab
C4
MSI-H/dMMR + TMB-H + PD-L1 overexpression
|
Small Intestinal Carcinoma
|
nivolumab + ipilimumab
pembrolizumab
C4
MSI-H/dMMR + TMB-H + PD-L1 overexpression
|
Pancreatic Ductal Adenocarcinoma
|
pembrolizumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login